Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/RPGLIFE stock hub

NSE/RPGLIFE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/RPGLIFEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40.7B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/RPGLIFE

In the news

Latest news · NSE/RPGLIFE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E35.4

P25 24.8P50 35.9P75 56.9

ROE20.3

P25 6.3P50 13.6P75 18.1

ROIC32.2

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/RPGLIFE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

INR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,331
Employees Change	61%
Employees Change Percent	4.8
Enterprise value	INR 38.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE105J01010
Last refreshed	2026-05-10
Market cap	INR 40.7B
Price	INR 2,477
Price currency	INR
Rev Per Employee	5,315,702.48x
Sector	Healthcare
Sic	2834
Symbol	nse/RPGLIFE
Website	https://www.rpglifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.83%
EV Earnings	33.15x
EV/EBIT	30.4x
EV/EBITDA	25.96x
EV/FCF	-430.96x
EV/Sales	5.4x
FCF yield	-0.22%
P/B ratio	6.73x
P/E ratio	35.37x
P/S ratio	5.76x
PE Ratio10 Y	28.78x
PE Ratio3 Y	28.29x
PE Ratio5 Y	24.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.75%
EBITDA Margin	20.79%
Gross margin	64.37%
Gross Profit	INR 4.6B
Gross Profit Growth	10.78%
Gross Profit Growth Q	44.38%
Gross Profit Growth3 Y	12.59%
Gross Profit Growth5 Y	13.66%
Net Income	INR 1.2B
Net Income Growth	-37.15%
Net Income Growth Q	-74.52%
Net Income Growth Years	6%
Net Income Growth3 Y	19.41%
Net Income Growth5 Y	23.55%
Pretax Margin	21.79%
Profit Margin	16.28%
Profit Per Employee	INR 865,289
Profitable Years	20
ROA	10.82
Roa5y	14.17
ROCE	19.86
ROE	20.28
Roe5y	26.45
ROIC	32.25
Roic5y	35.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	27.94%
Cagr15y	27.74%
Cagr1y	23.63%
Cagr3y	48.35%
Cagr5y	42.37%
Div CAGR10	23.97%
Div CAGR3	25.99%
Div CAGR5	27.23%
EPS Growth	-37.14
EPS Growth Q	-74.52
EPS Growth Years	6
EPS Growth3 Y	19.41
EPS Growth5 Y	23.56
OCF Growth	-27.43%
OCF Growth10 Y	5.59%
OCF Growth3 Y	-14.63%
OCF Growth5 Y	-0.62%
Revenue Growth	12.19x
Revenue Growth Q	32.29x
Revenue Growth Quarters	21x
Revenue Growth Years	6x
Revenue Growth3 Y	12.65x
Revenue Growth5 Y	13.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.98
Assets	INR 7.9B
Cash	INR 2.8B
Current Assets	INR 5.6B
Current Liabilities	INR 1.6B
Debt	INR 200M
Debt EBITDA	INR 0.14
Debt Equity	INR 0.03
Debt FCF	INR -2.26
Equity	INR 6.1B
Interest Coverage	141.1
Liabilities	INR 1.9B
Long Term Assets	INR 2.3B
Long Term Liabilities	INR 272.4M
Net Cash	INR 2.6B
Net Cash By Market Cap	INR 6.27
Net Cash Growth	-3.45%
Net Debt EBITDA	INR -1.74
Net Debt Equity	INR -0.42
Tangible Book Value	INR 6B
Tangible Book Value Per Share	INR 361
WACC	3.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.48
Inventory Turnover	2.33
Net Working Capital	INR 1.3B
Quick ratio	2.44
Working Capital	INR 4B
Working Capital Turnover	INR 1.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	50%
Dividend Growth Years	6%
Dividend per share	INR 24
Dividend Years	18
Dividend Yield	0.97%
Ex Div Date	2025-06-27
Last Dividend	INR 24
Payout Frequency	Annual
Payout Ratio	34.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,074.84%
1Y total return	23.62%
200-day SMA	2,210.4
3Y total return	226.58%
50-day SMA	1,965.6
50-day SMA vs 200-day SMA	50under200
5Y total return	484.76%
All Time High	2,975
All Time High Change	-16.74%
All Time High Date	2024-10-15
All Time Low	15.25
All Time Low Change	16,142.62%
All Time Low Date	2008-12-04
ATR	98.35
Beta	-0.2
Beta1y	0.25
Beta2y	0.32
Ch YTD	6.66
High	2,503.3
High52	2,725
High52 Date	2025-07-07
High52ch	-9.1%
Low	2,434.1
Low52	1,733
Low52 Date	2026-03-23
Low52ch	42.93%
Ma50ch	26.01%
Price vs 200-day SMA	12.06%
RSI	72.67
RSI Monthly	60.35
RSI Weekly	67.87
Sharpe ratio	0.55x
Sortino ratio	1.04
Total Return	0.98%
Tr YTD	6.66
Tr15y	3,836.38%
Tr1m	31%
Tr1w	2.48%
Tr3m	25.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.3B
Operating Income Growth	8.48
Operating Income Growth Q	85.66
Operating Income Growth3 Y	19.72
Operating Income Growth5 Y	23.02
Operating margin	17.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,395,931%
Net Borrowing	200,000,000
Shares Insiders	54.16%
Shares Institutions	5.44%
Shares Out	16,539,015
Shares Qo Q	-0.01%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -88.6M
Average Volume	114,848.5x
Bv Per Share	366
CAPEX	INR -653.6M
Ch10y	945.8
Ch15y	3,150.7
Ch1m	31
Ch1w	2.48
Ch1y	22.39
Ch3m	25.39
Ch3y	216.3
Ch5y	449.5
Ch6m	3.19
Change	-0.6%
Change From Open	-0.92
Close	2,492
Days Gap	0.32
Depreciation Amortization	214,800,000
Dollar Volume	38,705,602
Earnings Date	2026-04-29
EBIT	INR 1.3B
EBITDA	INR 1.5B
EPS	INR 69.64
F Score	3
FCF	INR -88.6M
FCF EV Yield	-0.23x
FCF Per Share	INR -5.36
Financing CF	-205,800,000
Fiscal Year End	March
Founded	1,968
Graham Number	757.33416
Graham Upside	-69.43
Income Tax	INR 390.3M
Investing CF	858,400,000
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	INR 1,640
Lynch Upside	-33.78
Ma150	2,153.9
Ma150ch	15%
Ma20	2,098.5
Ma20ch	18.04%
Net CF	1,217,600,000
Next Earnings Date	2026-07-24
Open	2,500
P OCF Ratio	72.1
Payment Date	2025-08-15
Position In Range	61.99
Ppne	2,117,200,000
Price Date	2026-05-08
Price EBITDA	INR 27.7
Ptbv Ratio	6.82
Relative Volume	0.14x
Revenue	7,075,200,000x
Tax By Revenue	5.52x
Tax Rate	25.31%
Tr6m	3.19%
Volume	15,626

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/RPGLIFE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$24.0 annual per share

Payout ratio

+34.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+27.2%

6 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2025-06-27

Performance

NSE/RPGLIFE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/RPGLIFE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.4%

Share of float held by funds and institutions

Insider ownership

+54.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/RPGLIFE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.7

Above 70: short-term overbought

Price vs 200-day MA

+12.1%

50/200-day relationship not available

Beta (5Y)

-0.20

Less volatile than the market

Sharpe ratio

0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/RPGLIFE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/RPGLIFE stock rating?

nse/RPGLIFE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/RPGLIFE analysis?

The full report lives at /stocks/nse/RPGLIFE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/RPGLIFE?

The latest report frames nse/RPGLIFE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/RPGLIFE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.